🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for HER2-negative Breast Cancer Patients With Brain Metastases

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases NCT06764940Phase 212 sites📍 Duarte📍 Los Angeles📍 San Diego Biostar Pharma, Inc. · Tests: Utidelone, Utidelone in combination with capecitabine, Utidelone in combination with capecitabine, Utidelone in combina… MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer NCT06247449NA1 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Brain imaging, Analysis of circulating tumor DNA, Testing Morbidities Index An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis NCT05376878Phase 41 site📍 Duarte City of Hope Medical Center · Tests: Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography, Trastuzumab, Trastuzumab Derux… UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases NCT05535413Phase 1, Phase 21 site📍 Changsha Hunan Cancer Hospital · Tests: UTD1 combined with capecitabine Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer NCT04348747Phase 23 sites📍 Tampa📍 Buffalo📍 Charlottesville Roswell Park Cancer Institute · Tests: Anti-HER2/HER3 Dendritic Cell Vaccine, Pembrolizumab Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients With Advanced HER2-Negative Breast Cancer With Brain Metastasis NCT06839560Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Adebrelimab+VEX Metronomic Chemotherapy+Concurrent Radiotherapy, Adebrelimab+VEX Metronomic Chemotherapy+Delayed Radiot… S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity NCT03418961Phase 3590 sites📍 Anchorage📍 Anchorage📍 Anchorage SWOG Cancer Research Network · Tests: Carvedilol, Laboratory Biomarker Analysis, Patient Observation Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. NCT05872347Phase 225 sites📍 Hefei📍 Hefei📍 Guangzhou Shanghai Pharmaceuticals Holding Co., Ltd · Tests: SPH4336 Tablets
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy